US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist

2.000
-0.140-6.53%

Trading Nov 19 12:35 ET

193.41MMarket Cap-836P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

31.71%-25.04M

6.12%-32.85M

-186.48%-44.1M

14.19%-118.69M

41.00%-31.63M

-1,770.75%-36.67M

34.00%-34.99M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

Net income from continuing operations

5.90%-43.97M

25.30%-36.54M

21.50%-46.61M

-52.78%-240.05M

-233.65%-85.03M

7.67%-46.73M

24.00%-48.92M

-256.37%-59.37M

31.69%-157.13M

25.87%-25.49M

Operating gains losses

-168.56%-870K

-318.61%-1.63M

402.68%3.76M

-89.39%4.32M

-62.79%1.56M

-96.06%1.27M

-57.75%747K

-70.25%747K

564.72%40.69M

82.46%4.18M

Depreciation and amortization

-9.38%802K

3.20%838K

16.60%843K

36.81%3.27M

33.18%847K

54.72%885K

38.57%812K

21.72%723K

-9.20%2.39M

-16.21%636K

Deferred tax

--0

2,388.96%37.1M

622.79%42.85M

-231.07%-578K

-23.41%-5.1M

98.21%-69K

93.78%-1.62M

122.76%5.93M

Other non cash items

11.52%7.65M

-33.69%7.04M

349.13%6.93M

168.11%17.3M

63.89%-1.71M

-52.68%6.86M

218.24%10.61M

105.89%1.54M

-48.97%-25.41M

49.54%-4.73M

Change In working capital

1,944.71%8.54M

-195.98%-4.82M

-130.15%-9.92M

190.86%44.27M

111.53%6.8M

90.05%-463K

-69.52%5.02M

2,221.92%32.91M

-210.15%-48.73M

-972.28%-59M

-Change in receivables

-146.55%-1.26M

69.68%319K

-95.92%2M

211.78%47.79M

91.95%-4M

211.53%2.7M

-96.81%188K

1,310.88%48.9M

-41.48%-42.75M

-246.94%-49.69M

-Change in inventory

74.71%-880K

125.24%518K

-63.22%-568K

40.81%-5.71M

104.76%167K

-86.74%-3.48M

47.75%-2.05M

1.97%-348K

-219.36%-9.65M

-69.95%-3.51M

-Change in payables and accrued expense

423.00%10.43M

-2,151.60%-7.03M

69.99%-4.79M

-166.26%-10.97M

-30.30%8.54M

-196.68%-3.23M

90.86%-312K

-464.20%-15.96M

-14.29%16.56M

25.38%12.25M

-Change in other current assets

-203.96%-1.37M

-109.92%-445K

-209.02%-701K

164.15%7.49M

108.59%1.05M

139.72%1.31M

-7.71%4.49M

160.38%643K

-83.67%-11.67M

-310.77%-12.16M

-Change in other current liabilities

-27.93%1.61M

-33.06%1.81M

-1,719.57%-5.86M

571.74%5.68M

117.90%1.05M

-59.17%2.23M

-72.56%2.71M

96.98%-322K

---1.2M

---5.88M

Cash from discontinued investing activities

Operating cash flow

31.71%-25.04M

6.12%-32.85M

-186.48%-44.1M

14.19%-118.69M

41.00%-31.63M

-1,770.75%-36.67M

34.00%-34.99M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

Investing cash flow

Cash flow from continuing investing activities

67.32%-216K

97.52%-30K

47.74%-531K

-368.12%-3.22M

-119.19%-327K

-160.24%-661K

-75.91%-1.21M

29.83%-1.02M

89.70%-687K

305.30%1.7M

Net PPE purchase and sale

67.32%-216K

97.52%-30K

47.74%-531K

-368.12%-3.22M

-52.80%-327K

-240.72%-661K

-2,324.00%-1.21M

-343.67%-1.02M

79.97%-687K

49.05%-214K

Cash from discontinued investing activities

Investing cash flow

67.32%-216K

97.52%-30K

47.74%-531K

-368.12%-3.22M

-119.19%-327K

-160.24%-661K

-75.91%-1.21M

29.83%-1.02M

89.70%-687K

305.30%1.7M

Financing cash flow

Cash flow from continuing financing activities

-351.86%-879K

35.01%98.7M

-16.24%356K

8,335.79%73.88M

99.96%-1K

-85.24%349K

29,108.73%73.1M

264.73%425K

-100.34%-897K

-125.94%-2.75M

Net issuance payments of debt

----

--0

----

137.79%115.6M

906.93%1.86M

Net common stock issuance

---1.23M

----

--0

----

--6.13M

---62K

Proceeds from stock option exercised by employees

10,579.37%37.27M

--41K

-16.24%356K

--773K

---1K

--349K

--0

--425K

--0

----

Net other financing activities

----

159.61%73.1M

--0

----

-156.25%-122.62M

-264.61%-4.55M

Cash from discontinued financing activities

Financing cash flow

-351.86%-879K

35.01%98.7M

-16.24%356K

8,335.79%73.88M

99.96%-1K

-85.24%349K

29,108.73%73.1M

264.73%425K

-100.34%-897K

-125.94%-2.75M

Net cash flow

Beginning cash position

-13.64%300.12M

-24.56%234.29M

-14.66%278.6M

-30.03%326.44M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

6.23%466.54M

-28.17%380.86M

Current changes in cash

29.33%-26.14M

78.37%65.82M

-176.98%-44.27M

65.67%-48.03M

41.53%-31.96M

-958.92%-36.99M

168.40%36.9M

55.09%-15.98M

-611.63%-139.9M

14.16%-54.66M

Effect of exchange rate changes

346.61%291K

-80.33%12K

-148.31%-43K

188.46%184K

-37.45%152K

47.32%-118K

142.07%61K

208.54%89K

-3,566.67%-208K

737.93%243K

End cash Position

-11.64%274.27M

-13.64%300.12M

-24.56%234.29M

-14.66%278.6M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

Free cash flow

32.34%-25.26M

9.19%-32.88M

-171.98%-44.63M

12.30%-121.9M

38.68%-31.96M

-2,023.44%-37.33M

32.74%-36.2M

53.12%-16.41M

42.02%-139M

16.16%-52.12M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	31.71%-25.04M	6.12%-32.85M	-186.48%-44.1M	14.19%-118.69M	41.00%-31.63M	-1,770.75%-36.67M	34.00%-34.99M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M
Net income from continuing operations	5.90%-43.97M	25.30%-36.54M	21.50%-46.61M	-52.78%-240.05M	-233.65%-85.03M	7.67%-46.73M	24.00%-48.92M	-256.37%-59.37M	31.69%-157.13M	25.87%-25.49M
Operating gains losses	-168.56%-870K	-318.61%-1.63M	402.68%3.76M	-89.39%4.32M	-62.79%1.56M	-96.06%1.27M	-57.75%747K	-70.25%747K	564.72%40.69M	82.46%4.18M
Depreciation and amortization	-9.38%802K	3.20%838K	16.60%843K	36.81%3.27M	33.18%847K	54.72%885K	38.57%812K	21.72%723K	-9.20%2.39M	-16.21%636K
Deferred tax	--0	--0	--0	2,388.96%37.1M	622.79%42.85M	-231.07%-578K	-23.41%-5.1M	98.21%-69K	93.78%-1.62M	122.76%5.93M
Other non cash items	11.52%7.65M	-33.69%7.04M	349.13%6.93M	168.11%17.3M	63.89%-1.71M	-52.68%6.86M	218.24%10.61M	105.89%1.54M	-48.97%-25.41M	49.54%-4.73M
Change In working capital	1,944.71%8.54M	-195.98%-4.82M	-130.15%-9.92M	190.86%44.27M	111.53%6.8M	90.05%-463K	-69.52%5.02M	2,221.92%32.91M	-210.15%-48.73M	-972.28%-59M
-Change in receivables	-146.55%-1.26M	69.68%319K	-95.92%2M	211.78%47.79M	91.95%-4M	211.53%2.7M	-96.81%188K	1,310.88%48.9M	-41.48%-42.75M	-246.94%-49.69M
-Change in inventory	74.71%-880K	125.24%518K	-63.22%-568K	40.81%-5.71M	104.76%167K	-86.74%-3.48M	47.75%-2.05M	1.97%-348K	-219.36%-9.65M	-69.95%-3.51M
-Change in payables and accrued expense	423.00%10.43M	-2,151.60%-7.03M	69.99%-4.79M	-166.26%-10.97M	-30.30%8.54M	-196.68%-3.23M	90.86%-312K	-464.20%-15.96M	-14.29%16.56M	25.38%12.25M
-Change in other current assets	-203.96%-1.37M	-109.92%-445K	-209.02%-701K	164.15%7.49M	108.59%1.05M	139.72%1.31M	-7.71%4.49M	160.38%643K	-83.67%-11.67M	-310.77%-12.16M
-Change in other current liabilities	-27.93%1.61M	-33.06%1.81M	-1,719.57%-5.86M	571.74%5.68M	117.90%1.05M	-59.17%2.23M	-72.56%2.71M	96.98%-322K	---1.2M	---5.88M
Cash from discontinued investing activities
Operating cash flow	31.71%-25.04M	6.12%-32.85M	-186.48%-44.1M	14.19%-118.69M	41.00%-31.63M	-1,770.75%-36.67M	34.00%-34.99M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M
Investing cash flow
Cash flow from continuing investing activities	67.32%-216K	97.52%-30K	47.74%-531K	-368.12%-3.22M	-119.19%-327K	-160.24%-661K	-75.91%-1.21M	29.83%-1.02M	89.70%-687K	305.30%1.7M
Net PPE purchase and sale	67.32%-216K	97.52%-30K	47.74%-531K	-368.12%-3.22M	-52.80%-327K	-240.72%-661K	-2,324.00%-1.21M	-343.67%-1.02M	79.97%-687K	49.05%-214K
Cash from discontinued investing activities
Investing cash flow	67.32%-216K	97.52%-30K	47.74%-531K	-368.12%-3.22M	-119.19%-327K	-160.24%-661K	-75.91%-1.21M	29.83%-1.02M	89.70%-687K	305.30%1.7M
Financing cash flow
Cash flow from continuing financing activities	-351.86%-879K	35.01%98.7M	-16.24%356K	8,335.79%73.88M	99.96%-1K	-85.24%349K	29,108.73%73.1M	264.73%425K	-100.34%-897K	-125.94%-2.75M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	137.79%115.6M	906.93%1.86M
Net common stock issuance	---1.23M	----	----	--0	--0	--0	----	----	--6.13M	---62K
Proceeds from stock option exercised by employees	10,579.37%37.27M	--41K	-16.24%356K	--773K	---1K	--349K	--0	--425K	--0	----
Net other financing activities	----	----	----	159.61%73.1M	--0	--0	----	----	-156.25%-122.62M	-264.61%-4.55M
Cash from discontinued financing activities
Financing cash flow	-351.86%-879K	35.01%98.7M	-16.24%356K	8,335.79%73.88M	99.96%-1K	-85.24%349K	29,108.73%73.1M	264.73%425K	-100.34%-897K	-125.94%-2.75M
Net cash flow
Beginning cash position	-13.64%300.12M	-24.56%234.29M	-14.66%278.6M	-30.03%326.44M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	6.23%466.54M	-28.17%380.86M
Current changes in cash	29.33%-26.14M	78.37%65.82M	-176.98%-44.27M	65.67%-48.03M	41.53%-31.96M	-958.92%-36.99M	168.40%36.9M	55.09%-15.98M	-611.63%-139.9M	14.16%-54.66M
Effect of exchange rate changes	346.61%291K	-80.33%12K	-148.31%-43K	188.46%184K	-37.45%152K	47.32%-118K	142.07%61K	208.54%89K	-3,566.67%-208K	737.93%243K
End cash Position	-11.64%274.27M	-13.64%300.12M	-24.56%234.29M	-14.66%278.6M	-14.66%278.6M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	-30.03%326.44M
Free cash flow	32.34%-25.26M	9.19%-32.88M	-171.98%-44.63M	12.30%-121.9M	38.68%-31.96M	-2,023.44%-37.33M	32.74%-36.2M	53.12%-16.41M	42.02%-139M	16.16%-52.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data